Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Catalyst begins phase II trial of CPP-109 for cocaine dependence

July 13, 2007

Recent Auspex patent discloses new treatment option for substance abuse and dependence

July 6, 2007

Positive phase I/II results for ALKS-29 in alcohol-dependent patients

July 4, 2007

New agents for substance abuse imparted in recent Auspex patent

June 25, 2007

NICE recommends use of Champix on U.K.'s National Health Service

June 1, 2007

Mucosal trivalent vaccine against botulism toxin identified at DOR BioPharma

May 31, 2007

NT69L and LY-379268 studied for possible use in nicotine addiction

May 29, 2007

Exjade labeling receives new Warning and Adverse Reactions information

May 28, 2007

Nalmefene licensing agreement enters into force

May 25, 2007

AEOL-10150 to be studied in mustard gas-mediated lung injury

May 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...